178 related articles for article (PubMed ID: 37629272)
1. Biomarkers of the L-Arginine/Dimethylarginine/Nitric Oxide Pathway in People with Chronic Airflow Obstruction and Obstructive Sleep Apnoea.
Hannemann J; Thorarinnsdottir EH; Amaral AFS; Schwedhelm E; Schmidt-Hutten L; Stang H; Benediktsdottir B; Gunnarsdóttir I; Gislason T; Böger R
J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629272
[TBL] [Abstract][Full Text] [Related]
2. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Lung; 2017 Dec; 195(6):717-727. PubMed ID: 28852826
[TBL] [Abstract][Full Text] [Related]
3. Relationship of asymmetric dimethylarginine levels with disease severity and pulmonary hypertension in chronic obstructive pulmonary disease.
Parmaksız ET; Inal A; Salepci B; Comert S; Fidan A; Kiral N; Doǧan C; Caglayan B
Lung India; 2018; 35(3):199-203. PubMed ID: 29697075
[TBL] [Abstract][Full Text] [Related]
4. L-Arginine Pathway in COPD Patients with Acute Exacerbation: A New Potential Biomarker.
Ruzsics I; Nagy L; Keki S; Sarosi V; Illes B; Illes Z; Horvath I; Bogar L; Molnar T
COPD; 2016; 13(2):139-45. PubMed ID: 26514682
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD.
Csoma B; Bikov A; Nagy L; Tóth B; Tábi T; Szűcs G; Komlósi ZI; Müller V; Losonczy G; Lázár Z
Respir Res; 2019 Jul; 20(1):156. PubMed ID: 31311549
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric dimethylarginine is not elevated in exfoliation syndrome but symmetric dimethylarginine is related to exfoliative glaucoma.
Blomster H; Puustjärvi T; Kontkanen M; Valtonen P; Teräsvirta M; Uusitalo H
Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):204-9. PubMed ID: 17024436
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
[TBL] [Abstract][Full Text] [Related]
8. Metabolites of the Nitric Oxide (NO) Pathway Are Altered and Indicative of Reduced NO and Arginine Bioavailability in Patients with Cardiometabolic Diseases Complicated with Chronic Wounds of Lower Extremities: Targeted Metabolomics Approach (LC-MS/MS).
Krzystek-Korpacka M; Wiśniewski J; Fleszar MG; Bednarz-Misa I; Bronowicka-Szydełko A; Gacka M; Masłowski L; Kędzior K; Witkiewicz W; Gamian A
Oxid Med Cell Longev; 2019; 2019():5965721. PubMed ID: 31396302
[TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients.
Fleck C; Janz A; Schweitzer F; Karge E; Schwertfeger M; Stein G
Kidney Int Suppl; 2001 Feb; 78():S14-8. PubMed ID: 11168976
[TBL] [Abstract][Full Text] [Related]
10. Plasma arginine metabolites in health and chronic kidney disease.
Au AYM; Mantik K; Bahadory F; Stathakis P; Guiney H; Erlich J; Walker R; Poulton R; Horvath AR; Endre ZH
Nephrol Dial Transplant; 2023 Nov; 38(12):2767-2775. PubMed ID: 37230955
[TBL] [Abstract][Full Text] [Related]
11. Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.
Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Kulkarni P; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Respir Res; 2017 Jan; 18(1):25. PubMed ID: 28114935
[TBL] [Abstract][Full Text] [Related]
12. Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA) Concentrations in Patients with Obesity and the Risk of Obstructive Sleep Apnea (OSA).
Arlouskaya Y; Sawicka A; Głowala M; Giebułtowicz J; Korytowska N; Tałałaj M; Nowicka G; Wrzosek M
J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31234586
[TBL] [Abstract][Full Text] [Related]
13. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide synthase inhibitors and hypertension in children and adolescents.
Goonasekera CD; Rees DD; Woolard P; Frend A; Shah V; Dillon MJ
J Hypertens; 1997 Aug; 15(8):901-9. PubMed ID: 9280214
[TBL] [Abstract][Full Text] [Related]
15. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.
Schulze F; Carter AM; Schwedhelm E; Ajjan R; Maas R; von Holten RA; Atzler D; Grant PJ; Böger RH
Atherosclerosis; 2010 Feb; 208(2):518-23. PubMed ID: 19700158
[TBL] [Abstract][Full Text] [Related]
16. Asymmetric dimethylarginine in chronic obstructive pulmonary disease (ADMA in COPD).
Scott JA; Duongh M; Young AW; Subbarao P; Gauvreau GM; Grasemann H
Int J Mol Sci; 2014 Apr; 15(4):6062-71. PubMed ID: 24727374
[TBL] [Abstract][Full Text] [Related]
17. Serum L-arginine and dimethylarginine levels in migraine patients with brain white matter lesions.
Erdélyi-Bótor S; Komáromy H; Kamson DO; Kovács N; Perlaki G; Orsi G; Molnár T; Illes Z; Nagy L; Kéki S; Deli G; Bosnyák E; Trauninger A; Pfund Z
Cephalalgia; 2017 May; 37(6):571-580. PubMed ID: 27206959
[TBL] [Abstract][Full Text] [Related]
18. Increased Serum Levels of Asymmetric Dimethylarginine and Symmetric Dimethylarginine and Decreased Levels of Arginine in Sudanese Patients with Essential Hypertension.
Gamil S; Erdmann J; Schwedhelm E; Bakheit KH; Abdalrahman IBB; Mohamed AO
Kidney Blood Press Res; 2020; 45(5):727-736. PubMed ID: 32814314
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis.
Chandrasekharan UM; Wang Z; Wu Y; Wilson Tang WH; Hazen SL; Wang S; Elaine Husni M
Arthritis Res Ther; 2018 Jun; 20(1):123. PubMed ID: 29884228
[TBL] [Abstract][Full Text] [Related]
20. Effect of Obstructive Sleep Apnea and CPAP Treatment on the Bioavailability of Erythrocyte and Plasma Nitric Oxide.
Mochol J; Gawryś J; Szahidewicz-Krupska E; Wiśniewski J; Fortuna P; Rola P; Martynowicz H; Doroszko A
Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
